Core Laboratories Appoints New CFO
Ticker: CLB · Form: 8-K · Filed: Mar 25, 2024 · CIK: 1958086
Sentiment: neutral
Topics: executive-appointment, cfo, leadership-change
TL;DR
Core Labs got a new CFO, Christopher van Dyck, starting March 25th. Big move for the energy services company.
AI Summary
Core Laboratories Inc. announced on March 21, 2024, the appointment of Christopher J. M. L. van Dyck as Chief Financial Officer, effective March 25, 2024. He will also serve as Senior Vice President. Van Dyck previously held the CFO position at TPC Group Inc. and has extensive experience in the energy and chemical industries.
Why It Matters
The appointment of a new CFO is a significant leadership change that can impact financial strategy and investor confidence.
Risk Assessment
Risk Level: medium — Changes in key executive positions like CFO can introduce uncertainty regarding future financial strategies and performance.
Key Players & Entities
- Core Laboratories Inc. (company) — Registrant
- Christopher J. M. L. van Dyck (person) — Appointed Chief Financial Officer and Senior Vice President
- TPC Group Inc. (company) — Previous employer of new CFO
- March 21, 2024 (date) — Date of Report
- March 25, 2024 (date) — Effective date of CFO appointment
FAQ
Who has been appointed as the new Chief Financial Officer of Core Laboratories Inc.?
Christopher J. M. L. van Dyck has been appointed as the new Chief Financial Officer and Senior Vice President of Core Laboratories Inc.
When is the new CFO's appointment effective?
The appointment of Christopher J. M. L. van Dyck is effective March 25, 2024.
What was Christopher J. M. L. van Dyck's previous role?
Christopher J. M. L. van Dyck previously served as the Chief Financial Officer of TPC Group Inc.
What is the principal executive office address for Core Laboratories Inc.?
The principal executive office address for Core Laboratories Inc. is 6316 Windfern Road, Houston, TX 77040.
What is the filing date of this Form 8-K?
This Form 8-K was filed on March 25, 2024, reporting events as of March 21, 2024.
Filing Stats: 617 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-03-25 16:38:09
Key Financial Figures
- $0.01 — ch registered Common Stock (par value $0.01) CLB New York Stock Exchange Indi
Filing Documents
- clb-20240321.htm (8-K) — 45KB
- 0000950170-24-035962.txt ( ) — 184KB
- clb-20240321.xsd (EX-101.SCH) — 48KB
- clb-20240321_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Core Laboratories Inc. Dated: March 25, 2024 By /s/ Christopher S. Hill Christopher S. Hill Chief Financial Officer